1 / 40

Genomics and High Throughput Sequencing Technologies: Applications

Genomics and High Throughput Sequencing Technologies: Applications. Jim Noonan Department of Genetics. Outline. Personal genome sequencing. Rationale: understanding human disease Variant discovery and interpretation Genome reduction strategies ( exome sequencing ).

lei
Download Presentation

Genomics and High Throughput Sequencing Technologies: Applications

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Genomics and High Throughput Sequencing Technologies: Applications Jim Noonan Department of Genetics

  2. Outline Personal genome sequencing • Rationale: understanding human disease • Variant discovery and interpretation • Genome reduction strategies (exome sequencing) Functional analysis of biological systems using sequencing • Transcriptome analysis: RNA-seq • Regulatory element discovery: ChIP-seq • Chromatin state profiling and the ‘histone code’ • Large-scale efforts: ENCODE and the NIH Epigenome Roadmap

  3. Whole genome sequencing: 1000 Genomes

  4. Nature 467:1061 (2010)

  5. The genetic architecture of human disease State, MW. Neuron 68:254 (2010)

  6. Challenge: Interpreting genetic variation Cooper and Shendure, Nat Rev Genet 12:628 (2011)

  7. Tools for identifying rare damaging mutations Protein-sequence based DNA-sequence based

  8. All humans have rare damaging mutations Damages protein Conserved Cooper and Shendure, Nat Rev Genet 12:628 (2011)

  9. Genome reduction: Exome sequencing Bamshad et al.Nat Rev Genet 12:745 (2011)

  10. Finding disease-causing rare variants by exome sequencing Screen unrelated trios for recurrence De novo mutation • Likely to have functional effect • Recurrence in independent affected individuals • Absence in controls • Reveal critical pathways in disease

  11. Sanders et al., Nature 485:237 (2012)

  12. Outline Personal genome sequencing • Rationale: understanding human disease • Variant discovery and interpretation • Genome reduction strategies (exome sequencing) • Challenges to de novo genome assembly using short reads Functional analysis of biological systems using sequencing • Transcriptome analysis: RNA-seq • Regulatory element discovery: ChIP-seq • Chromatin state profiling and the ‘histone code’ • Large-scale efforts: ENCODE and the NIH Epigenome Roadmap

  13. mRNA-seq workflow Wang et al. Nat Rev Genet 10:57 (2009) Martin and Wang Nat Rev Genet 12:671 (2011)

  14. Gene expression profiling by massively parallel RNA sequencing (RNA-seq)

  15. Mapping RNA-seq reads and quantifying transcripts

  16. Quantifying gene expression by RNA-seq • Use existing gene annotation: • Align to genome plus annotated splices • Depends on high-quality gene annotation • Which annotation to use: RefSeq, GENCODE, UCSC? • Isoform quantification? • Identifying novel transcripts? • Reference-guided alignments: • Align to genome sequence • Infer splice events from reads • Allows transcriptome analyses of genomes with poor gene annotation • De novo transcript assembly: • Assemble transcripts directly from reads • Allows transcriptome analyses of species without reference genomes

  17. RNA-seq reads mapped to reference Normalization methods: Reads per kilobase of feature length per million mapped reads (RPKM) • What is a “feature?” • What about genomes with poor genome annotation? • What about species with no sequenced genome? For a detailed comparison of normalization methods, see Bullard et al. BMC Bioinformatics 11:94.

  18. What depth of sequencing is required to characterize a transcriptome? Wang et al. Nat Rev Genet 10:57 (2009)

  19. Considerations • Gene length: • Long genes are detected before short genes • Expression level: • High expressors are detected before low expressors • Complexity of the transcriptome: • Tissues with many cell types require more sequencing • Feature type • Composite gene models • Common isoforms • Rare isoforms • Detection vs. quantification • Obtaining confident expression level estimates (e.g., “stable” RPKMs) requires greater coverage

  20. Pervasive alternative splicing in humans Wang et al. Nature 456:470 (2008)

  21. Composite gene model approach Map reads to genome Map remaining reads to known splice junctions • Requires good gene models • Isoforms are ignored • Which annotation to use: RefSeq, GENCODE, UCSC?

  22. Strategies for transcript assembly Garber et al. Nat Methods 8:469 (2011)

  23. ChIP-seq • Transcription factors • General transcription machinery • Modifications to histone tails • Methylated DNA

  24. Rationale: identifying regulatory elements in genomes Noonan and McCallion, Ann Rev Genomics Hum Genet 11:1 (2010)

  25. ChIP-seq peak calling ChIP-seq is an enrichment method Requires a statistical framework for determining the significance of enrichment ChIP-seq ‘peaks’ are regions of enriched read density relative to an input control Input = sonicated chromatin collected prior to immunoprecipitation

  26. There are many ChIP-seq peak calling methods Wilbanks and Facciotti PLoS ONE 5:e11471 (2010)

  27. The histone code Zhou et al. Nat Rev Genet 12:7 (2011)

  28. Mapping and analysis of chromatin state dynamics in nine human cell types • Cell types: • H1 ESC • K562 (erythrocyte derived) • GM12878 (B-lymphoblastoid) • HepG2 (hepatocellular carcinoma) • HUVEC (umbilical vein endothelium) • HSMM (skeletal muscle myoblasts) • NHLF (lung fibroblast) • NHEK (epidermal keratinocytes) • HMEC (mammary epithelium) • Marks: • H3K4me3 (promoter/enhancer) • H3K4me2 (promoter/enhancer) • H3K4me1 (enhancer) • H3K9ac (promoter/enhancer) • H3K27ac (promoter/enhancer) • H3K36me3 (transcribed regions) • H4K20me1 (transcribed regions) • H3K27me3 (Polycomb repression) • CTCF Ernst et al., Nature 473:43 (2011)

  29. Mapping and analysis of chromatin state dynamics in nine human cell types Ernst et al., Nature 473:43 (2011)

  30. Chromatin state dynamics at WLS Ernst et al., Nature 473:43 (2011)

  31. Functions associated with putative promoter and enhancer states • Annotation based on nearest TSS

  32. ChIP-seq: enhancer identification in vivo Visel et al. Nature 457:854 (2009) • p300 = enhancer-associated factor • p300 binding = ~90% predictive of • enhancer activity

  33. Systematic experimental annotation of regulatory functions Myers, PLoS Biol 9:e1001046 (2011)

  34. The ENCODE Project http://genome.ucsc.edu/ENCODE/

  35. The NIH Roadmap Epigenomics Project http://www.roadmapepigenomics.org/

  36. ENCODE cell lines Myers, PLoS Biol 9:e1001046 (2011)

  37. ENCODE Project data access http://genome.ucsc.edu/ENCODE/

  38. Genome Browser interface and data types Genome Viewer Categories of data: displayed as tracks Discrete intervals (genes) or continuous (transcription) • Hyperlinks and pulldown tabs for individual tracks • Go to track description page • Hide or show data in genome viewer • Some tracks include multiple datasets (‘subtracks’) • Go to track description page to select

  39. ENCODE Transcription track Display options Subtracks

  40. Conclusions Personal genomics is becoming a reality • Genome sequencing will be a routine diagnostic tool • $5,000 to sequence single genome; current cost for clinical resequencing of single genes • Your genome will be sequenced • Long-read sequencing will solve de novo assembly issues • Data analysis and interpretation RNA-seq and ChIP-seq • Identifying genes and annotating regulatory function within and among genomes • Computational issues: data normalization, peak calling, differential • expression and binding • Large-scale studies revealing regulatory architecture of human & model genomes

More Related